๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

AVE 0005 promising for neovascular age-related macular degeneration

Book ID
120848235
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2007
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Neovascular Age-Related Macular Degenera
Neovascular Age-Related Macular Degeneration
โœ Veritti, Daniele; Sarao, Valentina; Lanzetta, Paolo ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› S. Karger AG ๐ŸŒ English โš– 187 KB
Neovascular Age-Related Macular Degenera
Neovascular Age-Related Macular Degeneration
โœ Aimee V. Chappelow, Dr Peter K. Kaiser ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Springer International Publishing AG ๐ŸŒ English โš– 150 KB
Ranibizumab for Neovascular Age-Related
Ranibizumab for Neovascular Age-Related Macular Degeneration
โœ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Massachusetts Medical Society ๐ŸŒ English โš– 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha